Low-grade dysplasia in ulcerative colitis: Risk factors for developing high-grade dysplasia or colorectal cancer

American Journal of Gastroenterology

Volumn 110, Issue 10, 2015, Pages 1461-1471

  Choi, Chang Ho Ryan ^b   Ignjatovic Wilson, Ana ^a   Askari, Alan ^a   Lee, Gui Han ^a   Warusavitarne, Janindra ^a   Moorghen, Morgan ^a   Thomas Gibson, Siwan ^a   Saunders, Brian P ^a   Rutter, Matthew D ^c   Graham, Trevor A ^b,d   Hart, Ailsa L ^a,d  

^a ST MARK S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COLON; COLON DISEASE; COLON POLYP; COLONOSCOPY; COLORECTAL TUMOR; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; ULCERATIVE COLITIS;

AGED; COLITIS, ULCERATIVE; COLON; COLONIC DISEASES; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; CONSTRICTION, PATHOLOGIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84942645598     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.248     Document Type: Article

References (31)

1. Ullman T, Croog V, Harpaz N et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;5085:1311-9.
2. Bernstein C, Shanahan F, Weinstein W. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994, 71-5.
3. Blackstone MO, Riddell RH, Rogers BH et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-74.
4. Befrits R, Ljung T, Jaramillo E et al. Low-grade dysplasia in extensive, longstanding inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002;45:615-20.
5. Jess T, Loftus EV, Velayos FS et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis 2006;12:669-76.
6. Rutter MD, Saunders BP, Wilkinson KH et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8.
7. Ullman Ta, Loftus EV, Kakar S et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002;97:922-7.
8. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
9. Connell WR, Lennard-Jones JE, Williams CB et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
10. Dixon MF, BROWN LJR, Gilmour HM et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385-97.
11. Eaden J, Abrams K, McKay H et al. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152-7.
12. Fogt F, Urbanski SJ, Sanders ME et al. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Hum Pathol 2000;31:288-91.
13. Rubin PH, Friedman S, Harpaz N et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999;117:1295-300.
14. Odze RD, Farraye FA, Hecht JL et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004;2:534-41.
15. Kisiel JB, Loftus EV, Harmsen WS et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 2012;18:226-35.
16. Wanders LK, Dekker E, Pullens B et al. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol 2014;12:756-64.
17. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
18. Zisman TL, Bronner MP, Rulyak S et al. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis 2012;18:2240-6.
19. Odze RD, Brown CA, Hartmann CJ et al. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol 2000;24:1209-16.
20. Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
21. Subramanian V, Mannath J, Ragunath K et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:304-12.
22. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
23. Eide TJ. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 1986;38:173-6.
24. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
25. Pohl H, Srivastava A, Bensen SP et al. Incomplete polyp resection during colonoscopy - results of the complete adenoma resection (CARE) study. Gastroenterology 2013;1:74-80.
26. Doorn SC, van, Hazewinkel Y, East JE et al. Polyp morphology: an interobserver evaluation for the paris classification among international experts. Am J Gastroenterol 2015;110:180-7.
27. Thomas T, Abrams KA, Robinson RJ et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007;25:657-68.
28. van Schaik FD, ten Kate FJ, Offerhaus GJ et al. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia. Inflamm Bowel Dis 2011;17:1108-16.
29. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-41.
30. Lashner BA, Turner BC, Bostwick DG et al. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 1990;35:349-52.
31. Eaton JE, Smyrk TC, Imam M et al. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. Aliment Pharmacol Ther 2013;38:977-87.